ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIOS BioPlus Acquisition Corporation

10.795
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioPlus Acquisition Corporation NASDAQ:BIOS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.795 10.79 11.28 0 01:00:00

BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

14/03/2019 2:11am

GlobeNewswire Inc.


BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more BioPlus Acquisition Charts.

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has rescheduled the release of its fourth quarter and full year 2018 financial results from Thursday, March 14, 2019 to Friday, March 15, 2019, before the opening of the U.S. financial markets.  The Company will also be filing its Form 10-K annual report with the U.S. Securities and Exchange Commission on Friday, March 15, 2019.

Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen Deitsch, Senior Vice President, Chief Financial Officer and Treasurer, will host a conference call as follows:  

DateMarch 15, 2019
Time9:00 a.m. ET
Toll free (U.S.)(877) 423-9820
International(201) 493-6749 
Webcast (live and replay)https://78449.themediaframe.com/dataconf/productusers/bios/mediaframe/29020/indexl.html
 Or
 www.bioscrip.com

The online replay will be available within two hours of the call’s completion in the Investor Relations section of BioScrip’s web site at: www.bioscrip.com.

About BioScrip, Inc.BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Contacts 
Stephen DeitschKalle Ahl, CFA
Chief Financial Officer & TreasurerThe Equity Group
T: (720) 697-5200 T: (212) 836-9614
stephen.deitsch@bioscrip.comkahl@equityny.com

1 Year BioPlus Acquisition Chart

1 Year BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

Your Recent History

Delayed Upgrade Clock